Navigation Links
ASTRO releases SBRT for lung cancer report
Date:4/28/2010

The American Society for Radiation Oncology (ASTRO) has released its Emerging Technology Committee's report evaluating the use of stereotactic body radiotherapy (SBRT) in lung cancer treatment.

SBRT is a newer radiation therapy treatment that uses focused radiation beams to target a well-defined tumor and relies on detailed imaging, computerized three-dimensional treatment planning and precise treatment setup to deliver the radiation dose with extreme accuracy to any part of the body, excluding the brain or spine. It typically uses higher radiation doses in fewer treatments than other standard treatments.

Historically, the preferred treatment for lung cancer patients is surgery, but numerous lung cancer patients are unfit for surgery due to the presence of other medical conditions, such as cardiopulmonary disease related to chronic smoking, that put them at an unacceptably high risk of surgical morbidity and mortality. Traditionally six to seven weeks of radiation have been used for this group of patients, but studies showed a high risk of local failure.

Better response rates have been seen with smaller tumors and higher radiation doses, which is the technique employed by SBRT. This report states that SBRT is a good alternative to standard radiation for lung cancer patients who cannot receive surgery or refuse surgery because it uses high radiation doses in fewer treatments, thus minimizing exposure to surrounding normal tissue.

"Stereotactic radiotherapy is potentially more effective in tumor killing by delivering a few very large doses of daily radiotherapy from which cells will have limited ability to recover," Andre Konski, M.D., M.B.A., ASTRO's Emerging Technology Committee chair and chair of radiation oncology at Wayne State University in Detroit, said. "The committee believes that some lung cancer patients will greatly benefit from this treatment as it will shorten their treatment time and improve their quality of life."


'/>"/>

Contact: Nicole Napoli
nicolen@astro.org
703-839-7336
American Society for Radiation Oncology
Source:Eurekalert

Page: 1

Related medicine news :

1. ASTRO, ACR issue IGRT, SBRT guidelines
2. Astronaut Balancing Act: Training to Help Explorers Adapt to a Return to Gravity
3. 5,000 deaths: A catastrophic, regrettable decision in Belgium
4. Does Glutathione-S-transferase associate with gastrointestinal cancer in Korean population?
5. Why does percutaneous endoscopic gastrostomy fail to eliminate gastroesophageal reflux?
6. Senate Committee Advances Disastrous Idaho Health Freedom Act
7. ReportsandReports : The Gastrointestinal Market Outlook to 2014: Market Dynamics, Competitive Landscape, Emerging Therapies
8. ASTRO awards 17 Advocacy Day travel grants
9. ASTRO publishes supplement on protecting cancer patients by reducing radiation doses, side effects
10. Santa Monica Jury Rejects Claims of Catastrophic Brain Injury From Exposure to Mold; Plaintiff Faces Motions for Attorney Fees and Costs
11. Astrogenetix Narrows in on MRSA Virulence Onboard Discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... IL (PRWEB) , ... March 27, 2017 , ... ... systems, recently received the CE Certificate of Conformity for the Smart System® 20/20. ... or exceed the highest industry standards and specifications such as ANSI, ISO and ...
(Date:3/27/2017)... PA (PRWEB) , ... March 27, 2017 , ... ... business simulation -centric training, today announced the launch of a new research ... strategy, having the skills needed to execute that strategy, and the actual success ...
(Date:3/27/2017)... ... 2017 , ... According to the American Cancer Society , the average ... 95%. Once the cancer spreads to other organs, bones, or lymph nodes, however, the ... avoid this latter group, tune in to Lifestyle Magazine on April 9, ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... facility from 8:00am-10:00am on Monday, April 3rd to commemorate the two-year anniversary of ... opportunity for area-residents to celebrate two great years while also familiarizing themselves with ...
(Date:3/25/2017)... ... March 25, 2017 , ... Getting earned media coverage meaningful ... partner. , All through the year, Garden Media aims to provide material helpful ... key influencers and pitching client’s key messages to gain coveted media placements, ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 2017 BioLineRx Ltd. (NASDAQ/TASE: BLRX), a ... that AGI-134, an immunotherapy for the treatment of multiple cancers, ... be featured at the upcoming American Association for Cancer ... to be held on April 1-5, 2017. ... An abstract ...
(Date:3/27/2017)... 2017 The global clinical ... billion by 2025, according to a new study by ... diseases is anticipated to be responsible for the high ... the scope for growth during the forecast period. In ... is highly susceptible to chronic diseases, is presumed to ...
(Date:3/27/2017)... March 27, 2017  Impax Laboratories, Inc. (NASDAQ: IPXL)today ... Paul M. Bisaro as Impax,s President and Chief ... effective March 27, 2017. Mr. Bisaro will succeed ... President and Chief Executive Officer since December of 2016. ... branded pharmaceutical experience, Mr. Bisaro, 56, is an accomplished ...
Breaking Medicine Technology: